Xwell (XWEL) Other Non-Current Liabilities (2010 - 2025)

Xwell (XWEL) posted Other Non-Current Liabilities of $803000.0 for Q3 2025, down 22.49% sequentially from $1.0 million in Q2 2025.

Xwell (XWEL) Other Non-Current Liabilities (2010 - 2025) Analysis & Trends

Xwell has reported Other Non-Current Liabilities for 12 years, with the latest figure at $803000.0 in Q3 2025.

Quarterly Other Non-Current Liabilities changed N/A year-over-year to $803000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $803000.0 (changed N/A YoY) and the FY2020 annual result came in at $15.4 million, up 390.76% from the prior year.
Other Non-Current Liabilities retreated to $803000.0 in Q3 2025 per XWEL's latest filing, from $1.0 million in the prior quarter.
Over five years, Other Non-Current Liabilities peaked at $3.3 million in Q1 2025 and troughed at $803000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Thermo Fisher Scientific	234.15 Bn	230.09 Bn	8.34 Bn
2	Danaher	152.10 Bn	147.75 Bn	3.61 Bn
3	Natera	48.48 Bn	47.38 Bn	486.15 Mn
4	Agilent Technologies	44.35 Bn	42.55 Bn	990.00 Mn
5	Iqvia Holdings	43.68 Bn	41.60 Bn	1.44 Bn
6	Idexx Laboratories	43.02 Bn	42.83 Bn	779.09 Mn
7	Illumina	34.39 Bn	33.22 Bn	770.00 Mn
8	Mettler Toledo International	28.29 Bn	28.24 Bn	650.22 Mn
9	Labcorp Holdings	27.51 Bn	27.37 Bn	1.11 Bn
10	Xwell	8.44 Mn	-3.33 Mn	2.95 Mn

Download Data